Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$3.45 - $26.86 $1.34 Million - $10.4 Million
-387,632 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$20.4 - $25.15 $22,032 - $27,162
-1,080 Reduced 0.28%
387,632 $9.42 Million
Q4 2018

Feb 14, 2019

SELL
$16.55 - $30.22 $584,777 - $1.07 Million
-35,334 Reduced 8.33%
388,712 $7.82 Million
Q3 2018

Nov 14, 2018

BUY
$18.0 - $32.83 $7.63 Million - $13.9 Million
424,046 New
424,046 $13.1 Million

Others Institutions Holding ACER

# of Institutions
1
Shares Held
365
Call Options Held
0
Put Options Held
0

About Acer Therapeutics Inc.


  • Ticker ACER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,100,000
  • Description
  • Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...
More about ACER
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.